These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8392076)

  • 1. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis.
    Lashner BA
    J Cancer Res Clin Oncol; 1993; 119(9):549-54. PubMed ID: 8392076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study.
    Lashner BA; Heidenreich PA; Su GL; Kane SV; Hanauer SB
    Gastroenterology; 1989 Aug; 97(2):255-9. PubMed ID: 2568304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis.
    Lashner BA; Provencher KS; Seidner DL; Knesebeck A; Brzezinski A
    Gastroenterology; 1997 Jan; 112(1):29-32. PubMed ID: 8978339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis.
    Lashner BA; Provencher KS; Bozdech JM; Brzezinski A
    Am J Gastroenterol; 1995 Mar; 90(3):377-80. PubMed ID: 7872273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulcerative colitis and colon cancer: the role of surveillance.
    Broström O
    Ann Med; 1989 Aug; 21(4):309-11. PubMed ID: 2506915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis.
    Rozen P; Baratz M; Fefer F; Gilat T
    Gastroenterology; 1995 May; 108(5):1361-70. PubMed ID: 7729627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
    Löfberg R
    Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted?
    Gorfine SR; Bauer JJ; Harris MT; Kreel I
    Dis Colon Rectum; 2000 Nov; 43(11):1575-81. PubMed ID: 11089596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resections of ulcerative colitis associated with dysplasia or carcinoma.
    Sameshima S; Koketsu S; Takeshita E; Kubota Y; Okuyama T; Saito K; Ueda Y; Sawada T; Oya M
    World J Surg Oncol; 2015 Feb; 13():70. PubMed ID: 25884202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplasia and cancer complicating strictures in ulcerative colitis.
    Lashner BA; Turner BC; Bostwick DG; Frank PH; Hanauer SB
    Dig Dis Sci; 1990 Mar; 35(3):349-52. PubMed ID: 2307080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA
    Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia.
    Ransohoff DF; Riddell RH; Levin B
    Dis Colon Rectum; 1985 Jun; 28(6):383-8. PubMed ID: 4006632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
    Lindberg BU; Broomé U; Persson B
    Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of dysplasia in ulcerative colitis.
    Vatn MH; Elgjo K; Bergan A
    Scand J Gastroenterol; 1984 Oct; 19(7):893-5. PubMed ID: 6531658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program.
    Lashner BA; Silverstein MD; Hanauer SB
    Dig Dis Sci; 1989 Oct; 34(10):1536-41. PubMed ID: 2791805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2- and beta(2)-microglobulin-deficient mice.
    Carrier J; Medline A; Sohn KJ; Choi M; Martin R; Hwang SW; Kim YI
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1262-7. PubMed ID: 14652292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulcerative colitis and colorectal cancer. A population-based study.
    Ekbom A; Helmick C; Zack M; Adami HO
    N Engl J Med; 1990 Nov; 323(18):1228-33. PubMed ID: 2215606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rarity of adenomatous polyps in ulcerative colitis and its implications for colonic carcinogenesis.
    Ben-Horin S; Izhaki Z; Haj-Natur O; Segev S; Eliakim R; Avidan B
    Endoscopy; 2016 Mar; 48(3):215-22. PubMed ID: 26427000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial Dysplasia and Cancer in IBD Strictures.
    Sonnenberg A; Genta RM
    J Crohns Colitis; 2015 Sep; 9(9):769-75. PubMed ID: 26079724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing the cancer risk in chronic ulcerative colitis. A decision-analytic approach.
    Gage TP
    J Clin Gastroenterol; 1986 Feb; 8(1):50-7. PubMed ID: 3701012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.